CRYO-CELL INTERNATIONAL, INC. Revenue
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Revenue of $6.53 million for the 3-month period ending 2018-05-31, per its 10-Q filed 2018-07-16.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2018-07-16
- CRYO-CELL INTERNATIONAL, INC. revenues for the quarter ending 2018-05-31 was $6.53M, a 4.63% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. revenues for the quarter ending 2018-02-28 was $6.23M, a 7.82% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. revenues for the quarter ending 2017-11-30 was $6.47M, a 10.29% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. revenues for the quarter ending 2017-08-31 was $6.90M, a 8.91% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. revenues for fiscal 2017 was $25.38M, a 9.76% increase from fiscal 2016.
- CRYO-CELL INTERNATIONAL, INC. revenues for fiscal 2016 was $23.13M, a 9.66% increase from fiscal 2015.
- CRYO-CELL INTERNATIONAL, INC. revenues for fiscal 2015 was $21.09M, a 4.79% increase from fiscal 2014.
- CRYO-CELL INTERNATIONAL, INC. revenues for fiscal 2014 was $20.13M, a 5.96% increase from fiscal 2013.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-05-31 | $6.53M 10-Q · filed 2018-07-16 | $12.75M 10-Q · filed 2018-07-16 | $19.23M derived: sum of 3 quarters · filed 2018-07-16 | $26.12M derived: sum of 4 quarters · filed 2018-07-16 |
| 2018-02-28 | $6.23M 10-Q · filed 2018-04-16 | $12.70M derived: sum of 2 quarters · filed 2018-04-16 | $19.60M derived: sum of 3 quarters · filed 2018-04-16 | $25.84M derived: sum of 4 quarters · filed 2018-07-16 |
| 2017-11-30 | $6.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $13.37M derived: sum of 2 quarters · filed 2018-02-28 | $19.61M derived: sum of 3 quarters · filed 2018-07-16 | $25.38M 10-K · filed 2018-02-28 |
| 2017-08-31 | $6.90M 10-Q · filed 2017-10-16 | $13.13M derived: sum of 2 quarters · filed 2018-07-16 | $18.91M 10-Q · filed 2017-10-16 | $24.78M derived: sum of 4 quarters · filed 2018-07-16 |
| 2017-05-31 | $6.24M 10-Q · filed 2018-07-16 | $12.01M 10-Q · filed 2018-07-16 | $17.88M derived: sum of 3 quarters · filed 2018-07-16 | $24.22M derived: sum of 4 quarters · filed 2018-07-16 |
| 2017-02-28 | $5.78M 10-Q · filed 2018-04-16 | $11.65M derived: sum of 2 quarters · filed 2018-04-16 | $17.98M derived: sum of 3 quarters · filed 2018-04-16 | $23.75M derived: sum of 4 quarters · filed 2018-04-16 |
| 2016-11-30 | $5.87M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $12.20M derived: sum of 2 quarters · filed 2018-02-28 | $17.98M derived: sum of 3 quarters · filed 2018-02-28 | $23.13M 10-K · filed 2018-02-28 |
| 2016-08-31 | $6.33M 10-Q · filed 2017-10-16 | $12.10M derived: sum of 2 quarters · filed 2017-10-16 | $17.26M 10-Q · filed 2017-10-16 | $23.06M derived: sum of 4 quarters · filed 2017-10-16 |
| 2016-05-31 | $5.77M 10-Q · filed 2017-07-07 | $10.93M 10-Q · filed 2017-07-07 | $16.72M derived: sum of 3 quarters · filed 2017-07-07 | $22.16M derived: sum of 4 quarters · filed 2017-07-07 |
| 2016-02-29 | $5.15M 10-Q · filed 2017-04-13 | $10.95M derived: sum of 2 quarters · filed 2017-04-13 | $16.39M derived: sum of 3 quarters · filed 2017-04-13 | $21.40M derived: sum of 4 quarters · filed 2017-04-13 |
| 2015-11-30 | $5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $11.23M derived: sum of 2 quarters · filed 2017-02-28 | $16.25M derived: sum of 3 quarters · filed 2017-02-28 | $21.09M 10-K · filed 2017-02-28 |
| 2015-08-31 | $5.44M 10-Q · filed 2016-10-17 | $10.45M derived: sum of 2 quarters · filed 2016-10-17 | $15.29M 10-Q · filed 2016-10-17 | $20.27M derived: sum of 4 quarters · filed 2016-10-17 |
| 2015-05-31 | $5.01M 10-Q · filed 2016-07-11 | $9.86M 10-Q · filed 2016-07-11 | $14.83M derived: sum of 3 quarters · filed 2016-07-11 | $19.77M derived: sum of 4 quarters · filed 2016-07-11 |
| 2015-02-28 | $4.84M 10-Q · filed 2016-04-14 | $9.82M derived: sum of 2 quarters · filed 2016-04-14 | $14.76M derived: sum of 3 quarters · filed 2016-04-14 | $19.65M derived: sum of 4 quarters · filed 2016-04-14 |
| 2014-11-30 | $4.98M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $9.91M derived: sum of 2 quarters · filed 2016-02-29 | $14.81M derived: sum of 3 quarters · filed 2016-02-29 | $20.13M 10-K · filed 2016-02-29 |
| 2014-08-31 | $4.94M 10-Q · filed 2015-10-15 | $9.83M derived: sum of 2 quarters · filed 2015-10-15 | $15.15M 10-Q · filed 2015-10-15 | $19.86M derived: sum of 4 quarters · filed 2015-10-15 |
| 2014-05-31 | $4.89M 10-Q · filed 2015-07-15 | $10.21M 10-Q · filed 2015-07-15 | $14.92M derived: sum of 3 quarters · filed 2015-07-15 | $19.75M derived: sum of 4 quarters · filed 2015-07-15 |
| 2014-02-28 | $5.32M 10-Q · filed 2015-04-14 | $10.03M derived: sum of 2 quarters · filed 2015-03-02 | $14.86M derived: sum of 3 quarters · filed 2015-03-02 | $19.72M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-11-30 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $9.54M derived: sum of 2 quarters · filed 2015-03-02 | $14.39M derived: sum of 3 quarters · filed 2015-03-02 | $18.99M 10-K · filed 2015-03-02 |
| 2013-08-31 | $4.83M 10-Q · filed 2014-10-15 | $9.69M derived: sum of 2 quarters · filed 2014-10-15 | $14.29M 10-Q · filed 2014-10-15 | $19.11M derived: sum of 4 quarters · filed 2014-10-15 |
| 2013-05-31 | $4.86M 10-Q · filed 2014-07-03 | $9.46M 10-Q · filed 2014-07-03 | $14.28M derived: sum of 3 quarters · filed 2014-07-03 | $18.82M derived: sum of 4 quarters · filed 2014-07-03 |
| 2013-02-28 | $4.60M 10-Q · filed 2014-04-14 | $9.42M derived: sum of 2 quarters · filed 2014-04-14 | $13.97M derived: sum of 3 quarters · filed 2014-04-14 | $18.39M derived: sum of 4 quarters · filed 2014-04-14 |
| 2012-11-30 | $4.82M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $9.37M derived: sum of 2 quarters · filed 2014-02-28 | $13.79M derived: sum of 3 quarters · filed 2014-02-28 | $17.97M 10-K · filed 2014-02-28 |
| 2012-08-31 | $4.54M 10-Q · filed 2013-10-15 | $8.97M derived: sum of 2 quarters · filed 2013-10-15 | $13.15M 10-Q · filed 2013-10-15 | $17.58M derived: sum of 4 quarters · filed 2013-10-15 |
| 2012-05-31 | $4.43M 10-Q · filed 2013-07-15 | $8.60M 10-Q · filed 2013-07-15 | $13.04M derived: sum of 3 quarters · filed 2013-07-15 | $17.45M derived: sum of 4 quarters · filed 2013-07-15 |
| 2012-02-29 | $4.18M 10-Q · filed 2013-04-15 | $8.62M derived: sum of 2 quarters · filed 2013-04-15 | $13.02M derived: sum of 3 quarters · filed 2013-04-15 | $17.62M derived: sum of 4 quarters · filed 2013-04-15 |
| 2011-11-30 | $4.44M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $8.84M derived: sum of 2 quarters · filed 2013-02-28 | $13.45M derived: sum of 3 quarters · filed 2013-02-28 | $17.92M 10-K · filed 2013-02-28 |
| 2011-08-31 | $4.41M 10-Q · filed 2012-10-15 | $9.01M derived: sum of 2 quarters · filed 2012-10-15 | $13.48M 10-Q · filed 2012-10-15 | $18.06M derived: sum of 4 quarters · filed 2012-10-15 |
| 2011-05-31 | $4.60M 10-Q · filed 2012-07-16 | $9.07M 10-Q · filed 2012-07-16 | $13.65M derived: sum of 3 quarters · filed 2012-07-16 | $18.21M derived: sum of 4 quarters · filed 2012-07-16 |
| 2011-02-28 | $4.47M 10-Q · filed 2012-04-16 | $9.05M derived: sum of 2 quarters · filed 2012-04-16 | $13.61M derived: sum of 3 quarters · filed 2012-04-16 | |
| 2010-11-30 | $4.58M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-02-28 | $9.14M derived: sum of 2 quarters · filed 2012-02-28 | $17.76M 10-K · filed 2012-02-28 | |
| 2010-08-31 | $4.56M 10-Q/A · filed 2011-11-07 | $13.18M 10-Q/A · filed 2011-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |